The radial artery for coronary artery bypass grafting
- PMID: 16812988
- DOI: 10.2298/aci0503011n
The radial artery for coronary artery bypass grafting
Abstract
Coronary artery bypass grafting (CABG) is the standard surgical procedure for the treatment of advanced coronary artery disease. CABG surgery has been demonstrated to improve symptoms and, in specific subgroups of patients, to prolong life. Despite its success, the long-term outcome of coronary bypass surgery is strongly influenced by the fate of the vascular conduits used. Previous long-term studies have shown unsatisfactory patency of saphenous vein grafts used for myocardial revascularisation, compared with internal mammary artery grafts. Recently, the use of radial artery for CABG has enjoyed a revival, on the basis of the belief that it will help improving long-term results of coronary operations. The recent reports of encouraging mid-term and long-term patency rates of the radial artery, supports its continued use as a bypass conduit. In this paper, we review the current knowledge about the radial artery as a bypass graft, with special emphasis on the clinical results.
Similar articles
-
The fate of the radial artery conduit in coronary artery bypass grafting surgery.Eur J Cardiothorac Surg. 2006 Aug;30(2):341-6. doi: 10.1016/j.ejcts.2006.05.012. Epub 2006 Jul 7. Eur J Cardiothorac Surg. 2006. PMID: 16829081 Review.
-
The radial artery: which place in coronary operation?Ann Thorac Surg. 2000 Apr;69(4):1288-94. doi: 10.1016/s0003-4975(99)01089-9. Ann Thorac Surg. 2000. PMID: 10800849 Review.
-
Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.JAMA. 2011 Jan 12;305(2):167-74. doi: 10.1001/jama.2010.1976. JAMA. 2011. PMID: 21224458 Clinical Trial.
-
The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.Ann Thorac Surg. 2013 Jul;96(1):105-11. doi: 10.1016/j.athoracsur.2013.01.102. Epub 2013 May 16. Ann Thorac Surg. 2013. PMID: 23684156 Clinical Trial.
-
A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.J Cardiothorac Surg. 2019 Oct 15;14(1):174. doi: 10.1186/s13019-019-1010-z. J Cardiothorac Surg. 2019. PMID: 31615560 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical